Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
September 24, 2024 08:01 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within core activities in RNA delivery, supported by move into new...
Armlogi to Announce Fiscal Year 2024 Financial Results on Thursday, September 26
September 19, 2024 08:00 ET
|
Armlogi Holding Corp
WALNUT, CA, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive...
Banco Santander Chile: Announces Third Quarter 2024 Analyst and Investor Webcast / Conference Call
September 11, 2024 15:50 ET
|
Banco Santander Chile
SANTIAGO, Chile, Sept. 11, 2024 (GLOBE NEWSWIRE) -- You are cordially invited to participate in Banco Santander Chile's (NYSE: BSAC) conference call-webcast on Wednesday, October 30, 2024, at 11.00...
Retail Opportunity Investments Corp. Schedules Third Quarter Earnings Release and Conference Call
September 11, 2024 09:00 ET
|
Retail Opportunity Investments Corp.
Retail Opportunity Investments Corp. Schedules Third Quarter Earnings Release and Conference Call
Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024
September 05, 2024 07:00 ET
|
Agios Pharmaceuticals, Inc.
Agios is scheduled to present at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 10:20 a.m. ET.
Pharming Group to participate in September investor conferences
September 04, 2024 01:00 ET
|
Pharming Group N.V.
Leiden, the Netherlands, September 4, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor...
Arbutus to Participate in Two Upcoming Investor Conferences
September 03, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
August 27, 2024 07:00 ET
|
CytoSorbents
PRINCETON, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 26, 2024 09:00 ET
|
Optinose, Inc.
YARDLEY, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Broadwind Announces Second Quarter 2024 Results
August 13, 2024 07:00 ET
|
Broadwind, Inc.
CICERO, Ill., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today...